Julia Origüen

6PUBLICATIONS
28CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)BacteriologyDisease surveillancePredictive and prognostic markersMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 11, 2026
Randomized double-blind clinical trial evaluating the effectiveness and safety of secondary prophylaxis with oral vancomycin versus placebo in the prevention of recurrence of clostridioides difficile infection in patients receiving systemic antibiotic therapy (PREVAN trial).

Rafael San-Juan, Julia Origüen, Mario Fernández-Ruiz

|Sep 29, 2025
Effectiveness and Safety of Antibiotics in Kidney Transplant Recipients With Asymptomatic Bacteriuria: A Systematic Review and Meta-analysis of Randomized Controlled Trials.

Abdullah Tarik Aslan, Lokman Hekim Tanriverdi, Adrian V Hernandez

|Oct 16, 2024
Risk factors for poor outcome in adult patients with respiratory syncytial virus infection evaluated at the emergency department.

Manuel Gil-Mosquera, Ruth Gómez-Guerra, Elena Sanz-Rodríguez

|Dec 10, 2023
Predictive value of fecal calprotectin and lactoferrin levels for negative outcomes in Clostridioides difficile infection.

Mario Ágreda Fernández, Julia Origüen, Isabel Rodriguez-Goncer

|Feb 09, 2021
Efficacy and safety of oral fosfomycin for asymptomatic bacteriuria in kidney transplant recipients: Results from a Spanish multicenter cohort.

María Ruiz-Ruigómez, Mario Fernández-Ruiz, José Tiago Silva

|Nov 23, 2018
Toxin B PCR Amplification Cycle Threshold Adds Little to Clinical Variables for Predicting Outcomes in Clostridium difficile Infection: a Retrospective Cohort Study.

Julia Origüen, María Ángeles Orellana, Mario Fernández-Ruiz

Pageof 1

Frequent Collaborators

4 joint publications

Rafael San-Juan

4 joint publications

Francisco López-Medrano

3 joint publications

Mario Fernández-Ruiz

3 joint publications

José María Aguado